The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
Open accessAbstract
Objective To determine the associations of FGF23 with death, HF, and CVD and investigate the influence of CKD in a general community-living population. Background FGF23 increases renal phosphorus excretion and inhibits vitamin D activation. In ESRD, high FGF23 levels are associated with mortality. The associations of FGF23 with death, heart failure (HF), and cardiovascular disease (CVD) in teh general population are unknown. Methods Plasma FGF23 was measured in 3,107 community-living persons ≥ 65 years in 1996–97, and participants were followed through 2008. HF and CVD events were adjudicated by a panel of experts. Associations of FGF23 with each outcome were evaluated using Cox proportional hazards models, and we tested whether associations differed by CKD status. Results Both lower eGFR and higher urine ACR were associated with high FGF23 at baseline. During 10.5 years (median) follow-up, there were 1,730 deaths, 697 incident HF events, and 797 incident CVD events. Although high FGF23 concentrations were associated with each outcome in combined analyses, the associations were consistently stronger for those with CKD (P interactions all < 0.006). In the CKD group (n=1,128), the highest FGF23 quartile had adjusted hazards ratios (HR) of 1.87 (1.47, 2.38) for all-cause death, 1.94 (1.32, 2.83) for incident HF, and 1.49 (1.02, 2.18) for incident CVD events compared to the lowest quartile. Corresponding HRs in those without CKD (n=1,979) were 1.29 (1.05, 1.59), 1.37 (0.99, 1.89), and 1.07 (0.79, 1.45). Conclusions FGF23, a hormone involved in phosphorous and vitamin D homeostasis, is independently associated with all-cause death and incident HF in community-living older persons. These associations appear stronger in persons with CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman-Breen, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,249
Self-citationDobnig, H. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1340 · Cited by 1,209
Stevens, L. A., Coresh, J., Schmid, C. H., Feldman, H. I., Froissart, M., Kusek, J., Rossert, J., Van Lente, F., Bruce, R. D., Zhang, Y. (., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.018 · Cited by 1,037
Isakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study
Gottdiener, J. S., Arnold, A. M., Aurigemma, G. P., Polak, J. F., Tracy, R. P., Kitzman, D. W., Gardin, J. M., Rutledge, J. E., & Boineau, R. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00582-9 · Cited by 907
Gansevoort, R. T., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.531 · Cited by 883
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Surveillance and ascertainment of cardiovascular events
Ives, D. G., Fitzpatrick, A. L., Bild, D. E., Psaty, B. M., Kuller, L. H., Crowley, P. M., Cruise, R. G., & Theroux, S. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00093-9 · Cited by 688
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Recruitment of adults 65 years and older as participants in the cardiovascular health study
Tell, G. S., Fried, L. P., Hermanson, B., Manolio, T. A., Newman, A. B., & Borhani, N. O. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90062-9 · Cited by 556
Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., Seliger, S. L., Kestenbaum, B., Psaty, B., Tracy, R. P., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00003 · Cited by 540
Self-citationParker, B. D., Schurgers, L. J., Brandenburg, V. M., Christenson, R. H., Vermeer, C., Ketteler, M., Shlipak, M. G., Whooley, M. A., & Ix, J. H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-10-201005180-00004 · Cited by 457
Self-citationFGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Kendrick, J., Cheung, A. K., Kaufman, J. S., Greene, T., Roberts, W. L., Smits, G., & Chonchol, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121224 · Cited by 448
Self-citationMethods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study
Psaty, B. M., Kuller, L. H., Bild, D., Burke, G. L., Kittner, S. J., Mittelmark, M., Price, T. R., Rautaharju, P. M., & Robbins, J. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00092-8 · Cited by 446
How Fibroblast Growth Factor 23 Works
Liu, S., & Quarles, L. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010068 · Cited by 408
Cushman, M., Arnold, A. M., Psaty, B. M., Manolio, T. A., Kuller, L. H., Burke, G. L., Polak, J. F., & Tracy, R. P. (2005) · Circulation · doi:10.1161/circulationaha.104.504159 · Cited by 368
Mirza, M. A. I., Larsson, A., Melhus, H., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.013 · Cited by 341
Ix, J. H., Shlipak, M. G., Chertow, G. M., & Whooley, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.644286 · Cited by 326
Self-citationCystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
Sarnak, M. J., Katz, R., Stehman-Breen, C. O., Fried, L. F., Jenny, N. S., Psaty, B. M., Newman, A. B., Siscovick, D., Shlipak, M. G., & Study*, A. T. C. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00008 · Cited by 315
Self-citationElevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
Wolf, M., Molnar, M. Z., Amaral, A. P., Czira, M. E., Rudas, A., Ujszaszi, A., Kiss, I., Rosivall, L., Kosa, J., Lakatos, P., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080894 · Cited by 290
de Boer, I. H., Kestenbaum, B., Shoben, A. B., Michos, E. D., Sarnak, M. J., & Siscovick, D. S. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111157 · Cited by 283
Self-citationFoley, R. N., Collins, A. J., Ishani, A., & Kalra, P. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.016 · Cited by 274
Jan de Beur, S. M. (2005) · JAMA · doi:10.1001/jama.294.10.1260 · Cited by 250
Cystatin C Identifies Chronic Kidney Disease Patients at Higher Risk for Complications
Peralta, C. A., Katz, R., Sarnak, M. J., Ix, J., Fried, L. F., De Boer, I., Palmas, W., Siscovick, D., Levey, A. S., & Shlipak, M. G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050483 · Cited by 234
Self-citationCystatin C and Mortality Risk in the Elderly: The Health, Aging, and Body Composition Study
Shlipak, M. G., Fyr, C. L. W., Chertow, G. M., Harris, T. B., Kritchevsky, S. B., Tylavsky, F. A., Satterfield, S., Cummings, S. R., Newman, A. B., & Fried, L. F. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050545 · Cited by 216
Self-citationPredictors of heart failure among women with coronary disease
Bibbins-Domingo, K., Lin, F., Vittinghoff, E., Barrett-Connor, E., Hulley, S. B., Grady, D., & Shlipak, M. G. (2004) · Circulation · doi:10.1161/01.cir.0000141726.01302.83 · Cited by 171
Self-citationRenal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease
Shlipak, M. G., Simon, J. A., Grady, D., Lin, F., Wenger, N. K., & Furberg, C. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01450-4 · Cited by 171
Self-citationFibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study
Ix, J. H., Shlipak, M. G., Wassel, C. L., & Whooley, M. A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp699 · Cited by 133
Self-citationAssessment of cerebrovascular disease in the cardiovascular health study
Price, T. R., Psaty, B. M., O’Leary, D. H., Burke, G. L., & Gardin, J. M. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90105-d · Cited by 131
Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.02.012 · Cited by 103
Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly
Rifkin, D. E., Katz, R., Chonchol, M., Fried, L. F., Cao, J. J., de Boer, I. H., Siscovick, D. S., Shlipak, M. G., & Sarnak, M. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp646 · Cited by 97
Self-citationIx, J. H., Chonchol, M., Laughlin, G. A., Shlipak, M. G., & Whooley, M. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.06.011 · Cited by 80
Self-citationBibbins-Domingo, K. B., Chertow, G. M., Fried, L. F., Odden, M. C., Newman, A. B., Kritchevsky, S. B., Harris, T. B., Satterfield, S., Cummings, S. R., & Shlipak, M. G. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1396 · Cited by 63
Self-citationMeng, J., Wassel, C. L., Kestenbaum, B. R., Collins, T. C., Criqui, M. H., Lewis, C. E., Cummings, S. R., Ix, J. H., & for the Osteoporotic Fractures in Men (MrOS) Study Group (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq020 · Cited by 22
Self-citation
Cited by
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Scialla, J. J., Xie, H., Rahman, M., Anderson, A. H., Isakova, T., Ojo, A., Zhang, X., Nessel, L., Hamano, T., Grunwald, J. E., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050465 · Cited by 445
The Effects of High-Protein Diets on Kidney Health and Longevity
Ko, G.-J., Rhee, C. M., Kalantar-Zadeh, K., & Joshi, S. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010028 · Cited by 345
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Scialla, J. J., Lau, W. L., Reilly, M. P., Isakova, T., Yang, H.-Y., Crouthamel, M. H., Chavkin, N. W., Rahman, M., Wahl, P., Amaral, A. P., et al. (2013) · Kidney International · doi:10.1038/ki.2013.3 · Cited by 333
Coronary Artery Disease in Patients ≥80 Years of Age
Madhavan, M. V., Gersh, B. J., Alexander, K. P., Granger, C. B., & Stone, G. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.068 · Cited by 320
High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III
Chang, A. R., Lazo, M., Appel, L. J., Gutiérrez, O. M., & Grams, M. E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.073148 · Cited by 262
Metadata
- Authors
- Ix, J. H., Katz, R., Kestenbaum, B. R., de Boer, I. H., Chonchol, M., Mukamal, K. J., Rifkin, D., Siscovick, D. S., Sarnak, M. J., & Shlipak, M. G.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 60
- Issue
- 3
- Pages
- 200-207
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1803609188
- Cited by
- 324
- References
- 43
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.